Cipla Q4 Results: Reports and Full-Year FY25 Performance, Announces Special Dividend
Mumbai, India – Pharmaceutical major Cipla Q4 results announced robust financial results for the fourth quarter (Q4) and the full financial year 2024-25 (FY25), which concluded on March 31. The company reported a significant surge in profitability for both periods and declared a special dividend to commemorate its 90th anniversary.
Quarterly Highlights (Cipla Q4 Results FY25): Profits Soar, Revenue Climbs
For the fourth quarter of FY25, Cipla posted a consolidated net profit attributed to shareholders of ₹1,222 crore, marking a substantial 30 percent increase compared to the ₹939 crore reported in the corresponding quarter of the previous year. Consolidated revenue for Q4 FY25 also saw a healthy 9 percent year-on-year (Y-o-Y) growth, reaching ₹6,730 crore, up from ₹6,163 crore.
The company’s earnings before interest, tax, depreciation, and amortisation (EBITDA) for the quarter rose by 16.8 percent Y-o-Y to ₹1,537 crore. This growth was accompanied by an improved EBITDA margin, which expanded by 184 basis points to 22.84 percent from 21 percent in the same quarter last year.
However, sequentially, the consolidated net profit experienced a 22 percent decline from ₹1,570 crore in the preceding quarter (Q3 FY25). Similarly, revenue in Q4 FY25 slipped by 5 percent when compared to the December quarter’s ₹7,073 crore.
Revenue from the US market, Cipla’s largest contributor, saw a slight dip to $221 million from $226 million a year ago. The earnings per share (EPS) for the quarter stood at ₹15.13 (basic) and ₹15.12 (diluted).
Cipla Q4 Results and Full-Year Financial Strength (FY25): Sustained Growth
Looking at the entire financial year ending March 31, Cipla demonstrated strong growth. The pharmaceutical giant recorded a 28 percent rise in consolidated profit, reaching ₹5,273 crore, a significant jump from the ₹4,122 crore reported at the end of FY24. Consolidated revenue from operations for FY25 also climbed by 7 percent to ₹27,548 crore, compared to ₹25,774 crore in the previous financial year. The overall net profit for the year was ₹5,273 crore, up 28 percent, with an EPS of ₹65.29 (basic) and ₹65.24 (diluted).
Click Here Know More About Cipla Q4 Results
Special Dividend Announced After Cipla Q4 Results to Mark 90th Anniversary
In a move to celebrate its 90th anniversary, Cipla’s board of directors has proposed a final dividend of ₹13 per share (each share having a face value of ₹2) for FY25. Additionally, they have recommended a special dividend of ₹3 per share. This brings the total proposed dividend to ₹16 per share. The payment of this dividend is subject to shareholder approval at the Annual General Meeting and, if approved, will be disbursed within 30 days of the meeting.
Share Price Movement
Following the Cipla Q4 Results announcement of its March quarter earnings on Tuesday, May 13, shares of Cipla remained largely unchanged initially. However, the stock subsequently edged up by 0.45 percent to ₹1,518.80 on the BSE. On a year-to-date basis, the stock is currently down by 2 percent.
Disclaimer: This content is about intended solely for educational and informational purposes and should not be interpreted as financial or investment advice. The information presented is derived from publicly available sources and independent analysis; however, its accuracy or completeness is not guaranteed. Readers are encouraged to conduct their own due diligence and seek guidance from a professional financial advisor before making any investment decisions. Neither the author nor stoxmail.com assumes responsibility for any financial losses or investment actions taken based on this article.